SCHEMBL26111937

SCHEMBL26111937

Cc1ccc2nc(C(N)=O)c(=O)n(CC(O)C(O)C(O)CO)c2c1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.39
▸ USP2 O75604 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ CASP1 P29466 2/20 0.39
▸ BRCA1 P38398 2/20 0.39
▸ RECQL P46063 2/20 0.39
▸ CASP7 P55210 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ HAT1 O14929 2/20 0.39
▸ RBBP7 Q16576 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ HBB P68871 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26111945 1.00 MEN1 (0.39) MEN1USP2KMT2AKDM4ECASP1
SCHEMBL30621225 0.80 KMT2A (0.58) MEN1USP2KMT2AKDM4ECASP1
SCHEMBL22071670 0.80 KMT2A (0.58) MEN1USP2KMT2AKDM4ECASP1
SCHEMBL22071682 0.80 KMT2A (0.58) MEN1USP2KMT2AKDM4ECASP1
SCHEMBL26110110 0.77 CASP1 (0.47) MEN1USP2KMT2AKDM4ECASP1
SCHEMBL26110100 0.77 CASP1 (0.47) MEN1USP2KMT2AKDM4ECASP1
SCHEMBL16239990 0.70 MEN1 (0.59) MEN1USP2KMT2AKDM4ECASP1
SCHEMBL22071679 0.70 MEN1 (0.59) MEN1USP2KMT2AKDM4ECASP1
Water SCHEMBL16240843 0.69 MEN1 (0.58) MEN1USP2KMT2AKDM4ECASP1
SCHEMBL22071729 0.67 MEN1 (0.53) MEN1USP2KMT2AKDM4ECASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023191379-A1 3,4-DIHYDROQUINOXALINE-2-CARBOXIMIDE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR PREVENTING OR TREATING CANCER DISEASE 재단법인 대구경북첨단의료산업진흥재단 2023-10-05 — — WO disclosed
Send feedback